azelastine has been researched along with Rhinitis, Allergic, Perennial in 50 studies
azelastine: azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia
azelastine : A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.
Rhinitis, Allergic, Perennial: Inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year. The causes are usually air-borne allergens, particularly dusts, feathers, molds, animal fur, etc.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We recruited 24 subjects with perennial allergic rhinitis and randomized them in a double-blinded, crossover fashion, to receive placebo or azelastine two sprays BID, using Balaam's design." | 9.09 | Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. ( Berlin, JM; Chinchilli, V; Craig, TJ; Golden, S; Kakumanu, S; Lehman, EB; Lucus, T; Mauger, EA; Teets, SJ, 2000) |
| "Azelastine is a selective H(1)-receptor antagonist that inhibits histamine release and interferes with activation of several other mediators of allergic inflammation." | 6.71 | Topical azelastine in perennial allergic conjunctivitis. ( Canonica, GW; Ciprandi, G; Ellers-Lenz, B; Hermann, R; Kolb, C; Petzold, U, 2003) |
| "The effect of azelastine hydrochloride (AZ), an oral antiallergic drug, was evaluated in patients displaying otitis media with effusion (OME) accompanying allergic rhinitis." | 5.09 | Clinical efficacy of an antiallergic drug on otitis media with effusion in association with allergic rhinitis. ( Kawauchi, H; Mogi, G; Suzuki, M, 1999) |
| "We recruited 24 subjects with perennial allergic rhinitis and randomized them in a double-blinded, crossover fashion, to receive placebo or azelastine two sprays BID, using Balaam's design." | 5.09 | Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. ( Berlin, JM; Chinchilli, V; Craig, TJ; Golden, S; Kakumanu, S; Lehman, EB; Lucus, T; Mauger, EA; Teets, SJ, 2000) |
| "Azelastine is a selective H(1)-receptor antagonist that inhibits histamine release and interferes with activation of several other mediators of allergic inflammation." | 2.71 | Topical azelastine in perennial allergic conjunctivitis. ( Canonica, GW; Ciprandi, G; Ellers-Lenz, B; Hermann, R; Kolb, C; Petzold, U, 2003) |
| "Azelastine nasal spray was reported to control all rhinitis symptoms, including nasal congestion, regardless of rhinitis diagnosis during the 2-week study period." | 2.71 | Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. ( Kaliner, MA; Lieberman, P; Wheeler, WJ, 2005) |
| " Dosing was at the judgement of the investigator bearing in mind data sheet recommendations, i." | 2.68 | Topical therapy of allergic rhinitis in childhood: Allergodil nasal spray--non-sedating in children. ( Bähre, M; Höflich, C; Lassig, W; Roloff, A; Wober, W, 1996) |
| " In 73% of children the administered dose of azelastine was one spray puff per nostril twice daily, corresponding to the recommended daily, dosage of 0." | 2.68 | Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age. ( Bähre, M; Diez Crespo, CD; Wober, W, 1997) |
| "Azelastine nasal spray was generally administered at a dose of one spray puff (0." | 2.68 | Efficacy and tolerability of azelastine nasal spray in the treatment of allergic rhinitis: large scale experience in community practice. ( Bähre, M; Diez Crespo, C; Wober, W, 1997) |
| "Azelastine is a chemically novel medication that has been demonstrated to be clinically effective for asthma and seasonal allergic rhinitis." | 2.66 | Efficacy of azelastine in perennial allergic rhinitis: clinical and rhinomanometric evaluation. ( Cummins, LH; Hemsworth, GR; Meltzer, EO; Orgel, HA; Perhach, JL; Pierson, WE; Storms, WW, 1988) |
| " Pharmacokinetic studies have revealed no drug-drug interactions but a discrete increase in bioavailability of fluticasone propionate which was considered clinically unimportant." | 2.49 | New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis. ( Wolthers, OD, 2013) |
| "Azelastine nasal spray was more efficacious than placebo in the treatment of allergic rhinitis." | 2.44 | Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis. ( Lee, TA; Pickard, AS, 2007) |
| "Azelastine has demonstrated a wide range of pharmacologic effects on chemical mediators of inflammation including leukotrienes, kinins, and platelet activating factor in vitro and in vivo." | 2.44 | Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. ( Bernstein, JA, 2007) |
| " Nasal biopsy studies do not show any detrimental structural effects within the nasal mucosa with long-term administration of intranasal corticosteroids." | 2.42 | Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. ( Howarth, PH; Salib, RJ, 2003) |
| "Recent research has suggested that daytime somnolence in allergic rhinitis can be attributed to chronic inflammation of the nasal mucosa leading to nasal congestion and obstructed nasal passageways resulting in disturbed sleep." | 2.41 | Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. ( Craig, T; Glass, C; Kakumanu, S, 2002) |
| "Nonallergic rhinitis is a common disease that probably affects as many as 17 million Americans." | 2.41 | Update on nonallergic rhinitis. ( Lieberman, P; Settipane, RA, 2001) |
| "Azelastine was well tolerated in clinical trials and postmarketing surveys." | 2.40 | Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis. ( McNeely, W; Wiseman, LR, 1998) |
| " After nasal administration, azelastine is systemically absorbed with a bioavailability of about 40%." | 2.40 | Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis. ( Craig, TJ; Golden, SJ, 1999) |
| " The findings have implications for the long-term use of the MP 29-02." | 1.48 | Influence of MP 29-02 on ciliary beat frequency in human epithelial cells in vitro. ( Aderhold, C; Birk, R; Häussler, D; Kramer, B; Nastev, A; Sommer, JU; Stuck, BA; Wenzel, A, 2018) |
| "Respiratory and/or food allergy is common in children." | 1.35 | [Serous otitis media and allergy]. ( François, M, 2009) |
| "Pre-treatment with azelastine significantly inhibited both the LTC4 release and the increase in nasal vascular permeability." | 1.28 | Inhibitory effects of azelastine on nasal allergic responses in sensitized guinea pigs. ( Asakura, K; Kataura, A; Shirasaki, H; Sohma, S, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.00) | 18.7374 |
| 1990's | 24 (48.00) | 18.2507 |
| 2000's | 17 (34.00) | 29.6817 |
| 2010's | 8 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Häussler, D | 1 |
| Sommer, JU | 1 |
| Nastev, A | 1 |
| Aderhold, C | 1 |
| Wenzel, A | 1 |
| Kramer, B | 1 |
| Stuck, BA | 1 |
| Birk, R | 1 |
| Wolthers, OD | 1 |
| Mösges, R | 1 |
| Braido, F | 1 |
| Sclifò, F | 1 |
| Ferrando, M | 1 |
| Canonica, GW | 3 |
| May, U | 1 |
| Bousquet, J | 1 |
| Bachert, C | 1 |
| Bernstein, J | 1 |
| Carr, W | 1 |
| Dahl, R | 1 |
| Demoly, P | 1 |
| Devillier, P | 1 |
| Hellings, P | 1 |
| Fokkens, W | 1 |
| Klimek, L | 2 |
| Lieberman, P | 3 |
| Meltzer, E | 1 |
| Price, D | 1 |
| Ryan, D | 1 |
| Wahn, U | 1 |
| Poletti, SC | 1 |
| Sperl, A | 1 |
| Spielhaupter, M | 1 |
| Bardenhewer, C | 1 |
| Mullol, J | 1 |
| Hörmann, K | 1 |
| Hummel, T | 1 |
| François, M | 1 |
| Kaliner, MA | 2 |
| Ciprandi, G | 1 |
| Petzold, U | 4 |
| Kolb, C | 1 |
| Ellers-Lenz, B | 1 |
| Hermann, R | 1 |
| Salib, RJ | 1 |
| Howarth, PH | 1 |
| Kakumanu, S | 2 |
| Glass, C | 1 |
| Craig, T | 1 |
| Magnan, A | 1 |
| Wheeler, WJ | 1 |
| Gu, ZY | 1 |
| Lee, TA | 1 |
| Pickard, AS | 1 |
| Ghimire, A | 1 |
| Das, BP | 1 |
| Mishra, SC | 1 |
| Bernstein, JA | 1 |
| Narita, S | 1 |
| Asakura, K | 2 |
| Davies, RJ | 1 |
| Lund, VJ | 1 |
| Harten-Ash, VJ | 1 |
| Gastpar, H | 3 |
| Nolte, D | 1 |
| Aurich, R | 3 |
| Brendt, P | 1 |
| Enzmann, H | 2 |
| Giesemann, G | 1 |
| Kunkel, G | 1 |
| Renz, W | 2 |
| Schata, M | 1 |
| Grossman, J | 1 |
| Halverson, PC | 1 |
| Meltzer, EO | 2 |
| Shoenwetter, WF | 1 |
| van Bavel, JH | 1 |
| Woehler, TR | 1 |
| Freitag, JJ | 1 |
| Hemsworth, GR | 2 |
| Dorow, P | 2 |
| Gering, R | 1 |
| Köchy, HP | 1 |
| Philippe, A | 1 |
| Wendenburg, G | 1 |
| Lassig, W | 1 |
| Wober, W | 3 |
| Höflich, C | 1 |
| Bähre, M | 3 |
| Roloff, A | 1 |
| Kelso, JM | 1 |
| Herman, D | 1 |
| Garay, R | 1 |
| Le Gal, M | 2 |
| Yamagiwa, M | 1 |
| Diez Crespo, CD | 1 |
| Diez Crespo, C | 1 |
| Fujita, M | 1 |
| Yonetomi, Y | 1 |
| Takeda, H | 1 |
| Nakagawa, N | 1 |
| Kawabata, K | 1 |
| Ohno, H | 1 |
| McNeely, W | 1 |
| Wiseman, LR | 1 |
| Stern, MA | 1 |
| Wade, AG | 1 |
| Ridout, SM | 1 |
| Cambell, LM | 1 |
| Chicharro, JL | 1 |
| Lucía, A | 1 |
| Vaquero, AF | 1 |
| Pérez, M | 1 |
| Ito, H | 1 |
| Nakamura, Y | 1 |
| Takagi, S | 1 |
| Sakai, K | 1 |
| Suzuki, M | 1 |
| Kawauchi, H | 1 |
| Mogi, G | 1 |
| Pietrzkowicz, M | 1 |
| Grzelewska-Rzymowska, I | 1 |
| Golden, SJ | 2 |
| Craig, TJ | 4 |
| Golden, S | 1 |
| Teets, SJ | 1 |
| Lehman, EB | 2 |
| Mauger, EA | 1 |
| Chinchilli, V | 1 |
| Berlin, JM | 2 |
| Lucus, T | 1 |
| Teets, S | 1 |
| Lucas, T | 1 |
| Portmann, D | 1 |
| Jessent, V | 1 |
| Verrière, JL | 1 |
| Settipane, RA | 1 |
| Fukuishi, N | 1 |
| Matsuhisa, M | 1 |
| Shimono, T | 1 |
| Murata, N | 1 |
| Iwanaga, M | 1 |
| Sagara, H | 1 |
| Matsui, N | 1 |
| Akagi, M | 1 |
| Lurie, A | 1 |
| Saudubray, F | 1 |
| Eychenne, JL | 1 |
| Venot, A | 1 |
| de Lauture, D | 1 |
| Dessanges, JF | 1 |
| Lockhart, A | 1 |
| Strauch, G | 1 |
| Shirasaki, H | 1 |
| Sohma, S | 1 |
| Kataura, A | 1 |
| Storms, WW | 1 |
| Pierson, WE | 1 |
| Cummins, LH | 1 |
| Orgel, HA | 1 |
| Perhach, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acupuncture for Nasal Congestion in Allergic Rhinitis: An Open-Label, Randomized, Monocenter Trial (ANCAR Trial)[NCT05709977] | 62 participants (Anticipated) | Interventional | 2023-04-20 | Recruiting | |||
| A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection[NCT06008860] | Phase 4 | 280 participants (Anticipated) | Interventional | 2023-07-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for azelastine and Rhinitis, Allergic, Perennial
| Article | Year |
|---|---|
New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
Topics: Administration, Intranasal; Adolescent; Adrenal Cortex Hormones; Adult; Androstadienes; Animals; Dru | 2013 |
New therapies for allergic rhinitis.
Topics: Administration, Intranasal; Androstadienes; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibo | 2014 |
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
Topics: Administration, Intranasal; Androstadienes; Anti-Allergic Agents; Drug Combinations; Humans; Phthala | 2015 |
Azelastine and olopatadine in the treatment of allergic rhinitis.
Topics: Administration, Intranasal; Anti-Allergic Agents; Clinical Trials as Topic; Dibenzoxepins; Humans; O | 2009 |
Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.
Topics: Administration, Intranasal; Adrenal Cortex Hormones; Female; Histamine H1 Antagonists; Humans; Phtha | 2003 |
Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion.
Topics: Administration, Intranasal; Circadian Rhythm; Cromolyn Sodium; Disorders of Excessive Somnolence; Fl | 2002 |
Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis.
Topics: Administration, Intranasal; Anti-Allergic Agents; Cost-Benefit Analysis; Humans; Patient Satisfactio | 2007 |
Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Topics: Anti-Allergic Agents; Half-Life; Humans; Phthalazines; Randomized Controlled Trials as Topic; Rhinit | 2007 |
Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
Topics: Administration, Intranasal; Adult; Beclomethasone; Budesonide; Child; Drug Tolerance; Glucocorticoid | 1998 |
[Second generation topical antihistaminics].
Topics: Administration, Topical; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivit | 1999 |
Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis.
Topics: Administration, Inhalation; Histamine H1 Antagonists; Humans; Phthalazines; Rhinitis, Allergic, Pere | 1999 |
Update on nonallergic rhinitis.
Topics: Adrenal Cortex Hormones; Adult; Age of Onset; Air Pollution; Anti-Inflammatory Agents, Non-Steroidal | 2001 |
22 trials available for azelastine and Rhinitis, Allergic, Perennial
| Article | Year |
|---|---|
Topical azelastine in perennial allergic conjunctivitis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Analysis of Variance; Anti-Allergic Agents; Conjun | 2003 |
Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Histamine H1 | 2005 |
Comparative efficacy of steroid nasal spray versus antihistamine nasal spray in allergic rhinitis.
Topics: Adolescent; Adult; Aerosols; Aged; Anti-Allergic Agents; Beclomethasone; Female; Glucocorticoids; Hu | 2007 |
The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
Topics: Administration, Intranasal; Adult; Beclomethasone; Double-Blind Method; Female; Histamine H1 Antagon | 1993 |
Comparative efficacy of azelastine nasal spray and terfenadine in seasonal and perennial rhinitis.
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Double-Blind Method; Female; Ge | 1994 |
Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bronchodilator Agents; Child; Dose-Response Relations | 1994 |
Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis.
Topics: Administration, Intranasal; Adolescent; Adult; Aerosols; Aged; Female; Follow-Up Studies; Histamine | 1993 |
Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol.
Topics: Administration, Intranasal; Adolescent; Adult; Aerosols; Aged; Bronchodilator Agents; Budesonide; Fe | 1993 |
Topical therapy of allergic rhinitis in childhood: Allergodil nasal spray--non-sedating in children.
Topics: Administration, Intranasal; Child; Child, Preschool; Histamine H1 Antagonists; Humans; Phthalazines; | 1996 |
Study protocol on azelastine.
Topics: Anti-Allergic Agents; Chlorpheniramine; Data Interpretation, Statistical; Double-Blind Method; Drug | 1997 |
A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
Topics: Child; Double-Blind Method; Histamine H1 Antagonists; Humans; Phthalazines; Placebos; Random Allocat | 1997 |
Acoustic evaluation of the efficacy of medical therapy for allergic nasal obstruction.
Topics: Acoustics; Administration, Intranasal; Administration, Oral; Adult; Androstadienes; Anti-Allergic Ag | 1997 |
Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
Topics: Administration, Intranasal; Child; Child, Preschool; Female; Histamine H1 Antagonists; Humans; Male; | 1997 |
Efficacy and tolerability of azelastine nasal spray in the treatment of allergic rhinitis: large scale experience in community practice.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Child; | 1997 |
Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Budesonide; Double-Blind Method; Drug Tolerance | 1998 |
Effects of azelastine on the level of serum interleukin-4 and soluble CD23 antigen in the treatment of nasal allergy.
Topics: Adult; Anti-Allergic Agents; Dust; Female; Humans; Interleukin-4; Male; Middle Aged; Phthalazines; R | 1998 |
Clinical efficacy of an antiallergic drug on otitis media with effusion in association with allergic rhinitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Allergic Agents; Carbocysteine; Child; Child, Preschoo | 1999 |
Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis.
Topics: Administration, Topical; Adolescent; Adult; Circadian Rhythm; Cross-Over Studies; Double-Blind Metho | 2000 |
Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis.
Topics: Administration, Intranasal; Anti-Allergic Agents; Anti-Inflammatory Agents; Double-Blind Method; Flu | 2000 |
[Acceptability of local treatment of allergic rhinitis with a combination of a corticoid (beclomethasone) and an antihistaminic (azelastine)].
Topics: Administration, Inhalation; Adult; Beclomethasone; Drug Administration Schedule; Drug Therapy, Combi | 2000 |
Azelastine reduces allergen-induced nasal response: a clinical and rhinomanometric assessment.
Topics: Adult; Airway Resistance; Allergens; Female; Histamine H1 Antagonists; Humans; Male; Nose; Phthalazi | 1992 |
Efficacy of azelastine in perennial allergic rhinitis: clinical and rhinomanometric evaluation.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Humans; Middle Aged; Phthalazines; Pyridazines; | 1988 |
16 other studies available for azelastine and Rhinitis, Allergic, Perennial
| Article | Year |
|---|---|
Influence of MP 29-02 on ciliary beat frequency in human epithelial cells in vitro.
Topics: Administration, Intranasal; Adult; Androstadienes; Drug Combinations; Epithelial Cells; Female; Flut | 2018 |
All of ARIA in one puff?
Topics: Administration, Intranasal; Androstadienes; Anti-Allergic Agents; Asthma; Clinical Trials as Topic; | 2014 |
Azelastine and fluticasone nasal spray: any advantage?
Topics: Administration, Intranasal; Adolescent; Adult; Androstadienes; Anti-Allergic Agents; Drug Combinatio | 2014 |
[Socio-economic impact of allergic rhinitis and perspectives of appropriate therapy].
Topics: Absenteeism; Administration, Intranasal; Adolescent; Adult; Androstadienes; Asthma; Child; Child, Pr | 2014 |
Olfaction in patients with allergic rhinitis: an indicator of successful MP-AzeFlu therapy.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Female; Fluticasone; Humans; Male; Middle Aged; Phtha | 2017 |
[Serous otitis media and allergy].
Topics: Administration, Oral; Allergens; Animals; Anti-Allergic Agents; Child; Child, Preschool; Clinical Tr | 2009 |
[Respiratory allergies in the child and the adult].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Allergens; Anti-Allergic Ag | 2004 |
[Azelastine hydrochloride in the treatment of allergic rhinitis].
Topics: Histamine Antagonists; Humans; Phthalazines; Rhinitis, Allergic, Perennial | 2005 |
The effects of anti-PAF and other agents on the nasal symptoms in sensitized guinea pigs.
Topics: Airway Resistance; Animals; Azepines; Chromones; Guinea Pigs; Histamine H1 Antagonists; Immunization | 1993 |
Intranasal antihistamine gains marketing approval.
Topics: Administration, Intranasal; Adolescent; Adult; Drug Approval; Histamine H1 Antagonists; Humans; Midd | 1997 |
Azelastine nasal spray for allergic rhinitis.
Topics: Administration, Intranasal; Aerosols; Drug Interactions; Histamine H1 Antagonists; Humans; Phthalazi | 1997 |
Effects of a specific cysteinyl leukotriene antagonist, pranlukast, on antigen-induced cysteinyl leukotriene-mediated rhinitis in guinea pigs.
Topics: Airway Resistance; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Chromones; Cyclooxygenase I | 1997 |
Azelastine does not adversely affect aerobic performance.
Topics: Administration, Intranasal; Adolescent; Adult; Anaerobic Threshold; Anti-Allergic Agents; Conjunctiv | 1998 |
Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils.
Topics: Administration, Oral; Animals; Anti-Allergic Agents; Cell Movement; Dibenzoxepins; Eosinophils; Hist | 2002 |
Allergic rhinitis remains an important disease.
Topics: Cromolyn Sodium; Histamine H1 Antagonists; Humans; Immunotherapy; Leukotriene Antagonists; Phthalazi | 2002 |
Inhibitory effects of azelastine on nasal allergic responses in sensitized guinea pigs.
Topics: Animals; Capillary Permeability; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; Immunizat | 1992 |